标题
Combating multidrug-resistant Gram-negative bacterial infections
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 2, Pages 163-182
出版商
Informa Healthcare
发表日期
2013-11-12
DOI
10.1517/13543784.2014.848853
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- New β-lactam-β-lactamase inhibitor combinations in clinical development
- (2013) David M. Shlaes Annals of the New York Academy of Sciences
- Siderophore conjugates
- (2013) Malcolm G. P. Page Annals of the New York Academy of Sciences
- Single-Dose Safety, Tolerability, and Pharmacokinetics of the Antibiotic GSK1322322, a Novel Peptide Deformylase Inhibitor
- (2013) Odin J. Naderer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trihydroxamate Siderophore–Fluoroquinolone Conjugates Are Selective Sideromycin Antibiotics that Target Staphylococcus aureus
- (2013) Timothy A. Wencewicz et al. BIOCONJUGATE CHEMISTRY
- Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae
- (2013) R. Hartl et al. CLINICAL MICROBIOLOGY AND INFECTION
- Phage cocktails and the future of phage therapy
- (2013) Benjamin K Chan et al. Future Microbiology
- Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: a randomized placebo-controlled study
- (2013) O. J. Naderer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In VitroActivities of LTX-109, a Synthetic Antimicrobial Peptide, against Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, Daptomycin-Nonsusceptible, and Linezolid-Nonsusceptible Staphylococcus aureus
- (2012) Louis D. Saravolatz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors
- (2012) Pratik Bhagunde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
- (2012) Elizabeth B. Hirsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates
- (2012) Premavathy Levasseur et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anti-bacterial monoclonal antibodies: Back to the future?
- (2012) Martin B. Oleksiewicz et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers
- (2012) Cheng Ji et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
- (2012) Bruno François et al. CRITICAL CARE MEDICINE
- Making a beta-barrel: assembly of outer membrane proteins in Gram-negative bacteria
- (2012) Nathan W Rigel et al. CURRENT OPINION IN MICROBIOLOGY
- Strategies for the Discovery and Advancement of Novel Cationic Antimicrobial Peptides
- (2012) E. B. Hadley et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Development of Aminoglycoside Antibiotics Effective Against Resistant Bacterial Strains
- (2012) Lin Yang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Understanding efflux in Gram-negative bacteria: opportunities for drug discovery
- (2012) Herbert P Schweizer Expert Opinion on Drug Discovery
- Targeting iron assimilation to develop new antibacterials
- (2012) Timothy L Foley et al. Expert Opinion on Drug Discovery
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Resistance to antimicrobial peptides in Gram-negative bacteria
- (2012) Samantha Gruenheid et al. FEMS MICROBIOLOGY LETTERS
- Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes
- (2012) D. Roux et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes
- (2012) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of -lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104)
- (2012) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii
- (2012) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of Plazomicin (ACHN-490) against MDR clinical isolates ofKlebsiella pneumoniae, Escherichia coli, andEnterobacterspp. from Athens, Greece
- (2012) Irene Galani et al. JOURNAL OF CHEMOTHERAPY
- The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity
- (2012) A. M. van der Does et al. JOURNAL OF IMMUNOLOGY
- Targeting Pan-Resistant Bacteria With Antibodies to a Broadly Conserved Surface Polysaccharide Expressed During Infection
- (2012) David Skurnik et al. JOURNAL OF INFECTIOUS DISEASES
- Iron Transport-Mediated Drug Delivery: Practical Syntheses and In Vitro Antibacterial Studies of Tris-Catecholate Siderophore–Aminopenicillin Conjugates Reveals Selectively Potent Antipseudomonal Activity
- (2012) Cheng Ji et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoComparison of CXA-101 (FR264205) with and without Tazobactam versus Piperacillin-Tazobactam Using Human Simulated Exposures against Phenotypically Diverse Gram-Negative Organisms
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases
- (2011) P. R. S. Lagacé-Wiens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenems: Past, Present, and Future
- (2011) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Designed Antimicrobial and Antitumor Peptides with High Selectivity
- (2011) Jing Hu et al. BIOMACROMOLECULES
- Novel classes of antibiotics or more of the same?
- (2011) Anthony RM Coates et al. BRITISH JOURNAL OF PHARMACOLOGY
- Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches
- (2011) Andrea Giuliani et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Fidaxomicin: A Novel Macrocyclic Antibiotic Approved for Treatment of Clostridium difficile Infection
- (2011) A. A. Venugopal et al. CLINICAL INFECTIOUS DISEASES
- Appraising Contemporary Strategies to Combat Multidrug Resistant Gram-Negative Bacterial Infections–Proceedings and Data From the Gram-Negative Resistance Summit
- (2011) Marin H. Kollef et al. CLINICAL INFECTIOUS DISEASES
- Challenges of Antibacterial Discovery
- (2011) L. L. Silver CLINICAL MICROBIOLOGY REVIEWS
- Pharmacokinetics and Unexpected Safety Issues of LBM415, a Novel Oral Peptide Deformylase Inhibitor
- (2011) P Rolan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14– and CTX-M-15–producing Escherichia coli and Klebsiella pneumoniae
- (2011) Emilia Titelman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A Physiologically Based Pharmacokinetic Model Characterizing Mechanism-based Inhibition of CYP1A2 for Predicting Theophylline/Antofloxacin Interaction in both Rats and Humans
- (2011) Xian Pan et al. Drug Metabolism and Pharmacokinetics
- Towards new business models for R&D for novel antibiotics
- (2011) A.D. So et al. DRUG RESISTANCE UPDATES
- Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now
- (2011) Laura Freire-Moran et al. DRUG RESISTANCE UPDATES
- Monoclonal Antibodies in Infectious Diseases: Clinical Pipeline in 2011
- (2011) Jan ter Meulen INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
- (2011) Z. Aktaş et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The revival of fosfomycin
- (2011) Argyris S. Michalopoulos et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Correlation of the antimicrobial activity of ME1036 with its binding affinities to the penicillin-binding proteins from Streptococcus pneumoniae strains
- (2011) Yoko Hirai et al. JOURNAL OF ANTIBIOTICS
- Antibiotics in the clinical pipeline in 2011
- (2011) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
- (2011) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
- (2011) Q. Lu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synthetic Mimics of Antimicrobial Peptides from Triaryl Scaffolds
- (2011) Hitesh D. Thaker et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
- (2011) Johan Isaksson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antimicrobial Peptides – Promising Alternatives to Conventional Antibiotics
- (2011) Sylvia A. Baltzer et al. JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY
- Antibiotic bill doesn't GAIN enough ground
- (2011) Paul G. Ambrose NATURE MEDICINE
- A Concise Synthesis of a β-Lactamase Inhibitor
- (2011) Ian K. Mangion et al. ORGANIC LETTERS
- Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity Model
- (2010) William C. Wimley ACS Chemical Biology
- Doripenem: A new carbapenem antibiotic
- (2010) E. B. Chahine et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- In Vitro Potentiation of Carbapenems with ME1071, a Novel Metallo- -Lactamase Inhibitor, against Metallo- -Lactamase- Producing Pseudomonas aeruginosa Clinical Isolates
- (2010) Y. Ishii et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cationic Amphiphiles, a New Generation of Antimicrobials Inspired by the Natural Antimicrobial Peptide Scaffold
- (2010) B. Findlay et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
- (2010) M. G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation and Target Validation of Indole Derivatives as Inhibitors of the AcrAB-TolC Efflux Pump
- (2010) Bo ZENG et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Macromolecular Inhibition of Quorum Sensing: Enzymes, Antibodies, and Beyond
- (2010) Neri Amara et al. CHEMICAL REVIEWS
- Workshop on Clinical Trials of Antibacterial Agents for Hospital‐Acquired Pneumonia and Ventilator‐Associated Pneumonia
- (2010) John G. Bartlett et al. CLINICAL INFECTIOUS DISEASES
- Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study
- (2010) Diamantis P. Kofteridis et al. CLINICAL INFECTIOUS DISEASES
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Effect of 1-(1-Naphtylmethyl)-piperazine, an Efflux Pump Inhibitor, on Antimicrobial Drug Susceptibilities of Clinical Acinetobacter baumannii Isolates
- (2010) Ahmet Yilmaz Coban et al. CURRENT MICROBIOLOGY
- Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
- (2010) Karen Bush CURRENT OPINION IN MICROBIOLOGY
- Combating evolution with intelligent design: the neoglycoside ACHN-490
- (2010) Eliana S Armstrong et al. CURRENT OPINION IN MICROBIOLOGY
- Current Challenges in Antimicrobial Chemotherapy
- (2010) Carine Bebrone et al. DRUGS
- The role of talactoferrin alfa in the treatment of non-small cell lung cancer
- (2010) Ronan J Kelly et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains
- (2010) Jacqueline Chevalier et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Investigation of pneumonia-causing pathogenic organisms in children and the usefulness of tebipenem pivoxil for their treatment
- (2010) Haruo Kuroki et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Permeability of a novel β-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunumin vitro
- (2010) Petra Igličar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates
- (2010) A. Mahamoud et al. MICROBIOLOGY-SGM
- Up against the wall
- (2010) Christian Torres NATURE MEDICINE
- Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli
- (2010) B. Bommarius et al. PEPTIDES
- De Novo Design of Antimicrobial Polymers, Foldamers, and Small Molecules: From Discovery to Practical Applications
- (2009) Gregory N. Tew et al. ACCOUNTS OF CHEMICAL RESEARCH
- Antimicrobial Peptide hLF1-11 Directs Granulocyte-Macrophage Colony-Stimulating Factor-Driven Monocyte Differentiation toward Macrophages with Enhanced Recognition and Clearance of Pathogens
- (2009) A. M. van der Does et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing Escherichia coli
- (2009) E. L. Lopez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sideromycins: tools and antibiotics
- (2009) Volkmar Braun et al. BIOMETALS
- Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)
- (2009) Walter JFM van der Velden et al. BMC Medicine
- Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models
- (2009) Evelina Rubinchik et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Resistance development profiling of piperacillin in combination with the novel -lactamase inhibitor BLI-489
- (2009) A. Ruzin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters
- (2009) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structure−Activity Relationships of Polymyxin Antibiotics
- (2009) Tony Velkov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal Structures of the Human and Fungal Cytosolic Leucyl-tRNA Synthetase Editing Domains: A Structural Basis for the Rational Design of Antifungal Benzoxaboroles
- (2009) Elena Seiradake et al. JOURNAL OF MOLECULAR BIOLOGY
- Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
- (2009) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors
- (2009) Laurent Mamelli et al. PLoS One
- In Vitro Activity of LK-157, a Novel Tricyclic Carbapenem As Broad-Spectrum -Lactamase Inhibitor
- (2008) S. Paukner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Topical versus Systemic Antimicrobial Therapy for Treating Mildly Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double‐Blinded, Multicenter Trial of Pexiganan Cream
- (2008) Benjamin A. Lipsky et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Temocillin revived
- (2008) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
- (2008) Louis B. Rice JOURNAL OF INFECTIOUS DISEASES
- Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis
- (2008) M. P. Venkatesh et al. JOURNAL OF MEDICAL MICROBIOLOGY
- The Bacteria Fight Back
- (2008) G. Taubes SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now